# DENTSPLY SIRONA Inc. (XRAY) · Edgar & Edgarette company card

> Dentsply Sirona (XRAY) saw revenue fall 3.0% in FY2025 to $3.7 billion, operating margin -11.5% against a 3.7% median for dental equipment & supplies, equity 24.7% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 818479 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/XRAY) · [JSON](https://www.pops4.com/boards/company/XRAY.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $3.7B |
| Revenue growth, 1 year | -3.0% |
| Revenue growth per year | -3.4% |
| Operating margin | -11.5% (prior year -23.2%) |
| Net margin | -16.3% |
| Operating cash flow | $235M |
| Capital spending | $131M |
| Free cash flow | $104M |
| Cash | $326M |
| Long-term debt | $2.3B |
| Total assets | $5.4B |
| Total equity | $1.3B |
| Equity ÷ assets | 24.7% |
| Return on equity | -44.7% |
| Dividend per share | $0.64 |
| Dividend years rising | 0 |

## Readings, computed from those figures

- Altman Z: -0.3 (distress zone)
- Piotroski F: 6 of 9 (solid)
- Health Harbor boat: Sound ship · one warning sign · operating loss: a margin of -11.5% in FY2025
- Cash Compass: Steady earner · steady and paying a dividend, with average cash

## Edgarette's reading

Exposure: revenue $3.7B (FY2025), total debt $2.3B. Experience: revenue down 3.0% on the year, down 3.4% a year over 4 years; operating margin -11.5%, up from -23.2%. Soundness: equity 24.7% of assets, return on equity -44.7%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $3.2B and $3.8B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $3.0B to $4.1B. A statistical range, not company guidance. Against peers (90 filers, $50M+ revenue, its industry group): operating margin -11.5% against a 3.7% median; growth -3.0% against 9.9%.

Range logged 2026-10-12, receipt 03b5fa0c1a7e6eba, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-06-11 ([filing](https://www.sec.gov/Archives/edgar/data/818479/000081847926000200/0000818479-26-000200-index.htm))

## Recent filings

- 10-Q · filed 2026-11-05 · [filing](https://www.sec.gov/Archives/edgar/data/818479/000081847926000287/0000818479-26-000287-index.htm)
- 8-K · filed 2026-11-05 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/818479/000081847926000285/0000818479-26-000285-index.htm)
- 8-K · filed 2026-10-09 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/818479/000081847926000278/0000818479-26-000278-index.htm)
- 10-Q · filed 2026-08-06 · [filing](https://www.sec.gov/Archives/edgar/data/818479/000081847926000255/0000818479-26-000255-index.htm)
- 8-K · filed 2026-08-06 · 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/818479/000081847926000253/0000818479-26-000253-index.htm)
- 8-K · filed 2026-06-11 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/818479/000081847926000200/0000818479-26-000200-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000818479.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=818479

## Cite

POPS4, Edgar & Edgarette: DENTSPLY SIRONA Inc. (XRAY) company card, from the company's own SEC filings, accessed 2026-11-21, https://www.pops4.com/boards/company/XRAY. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

